MyFinsight
Home
Blog
About
Contact
Short-term marketable
securities
$140,030K
Cash and cash
equivalents
$35,719K
Prepaid expenses and
other current assets
$9,352K
Property, plant and
equipment, gross
$21,663K
Total current assets
$185,101K
Right-of-use assets
$17,920K
Goodwill
$14,072K
Property and equipment,
net
$6,556K
Other non-current
assets
$5,261K
Intangible asset
$160K
Less accumulated
depreciation
$15,107K
Total assets
$229,070K
Accumulated deficit
-$606,401K
Accumulated other
comprehensive income (loss)
-$147K
Total liabilities,
convertible preferred...
$229,070K
Total stockholders
deficit
-$523,694K
Additional paid-in capital
$82,854K
Convertible preferred
stock-Series APreferred...
$216,503K
Convertible preferred
stock-Series DPreferred...
$196,031K
Convertible preferred
stock-Series BPreferred...
$167,765K
Convertible preferred
stock-Series CPreferred...
$123,259K
Total liabilities
$49,206K
Total current
liabilities
$22,211K
Lease liabilities,
non-current
$20,753K
Contingent consideration
and warrant...
$6,242K
Accrued expenses and
other current...
$8,618K
Accounts payable
$8,219K
Lease liabilities,
current
$5,374K
Back
Back
Balance Sheet
source: myfinsight.com
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. (ODTX)